About the webinar

Wednesday, October 13, 2021 | 11:00 am -12:00 pm EST

Breakthrough treatments, such as mRNA and personalized therapies, have created tremendous opportunities for pharmaceutical companies but require intricate manufacturing, supply chain and quality control processes that are difficult to support. In addition, these complex products are coming to market faster than ever, leaving less time to develop and optimize the manufacturing process.

This combination of product complexity and compressed timeframes highlights the need for a digital thread that can securely connect siloed teams and datasets.

By embracing technologies like Cloud, AI and machine learning, these companies are able to deliver more personalized products faster and improve the patient experience.

AWS and Accenture are collaborating at several pharmaceutical companies to transform these processes. In this session, we will identify key learnings and patterns such as how data is being used to optimize clinical trials, accelerate products to market and expand their pipelines to become more patient-centric.


Image Thumbnail

Accenture AWS Business Group (AABG)

Turning innovations rapidly into business value


Stuart Henderson

Client Account Lead – North America

Dan Sheeran

Healthcare and Life Sciences Director – AWS

Barry Heavey

Managing Director – Life Sciences, Europe

View All

Accenture + AWS

Platform plays are key enablers for the connected and data driven future in life sciences. The unique business relationship between Accenture and AWS brings you deep technical expertise, extensive AWS experience and breakthrough innovations.

We bring together technology and scalability to move beyond ideas to practical innovations. By working with the Accenture AWS Business Group, you can access the cultures, capabilities and tools of two leading innovators.

In this example, Accenture, AWS and Takeda started thinking outside of the box to think about business challenges and cloud transformation very differently. They called this the Power of Three. And, ultimately, the focus was on Takeda’s patients and how innovation at a rapid speed allowed them to move from treating conditions to keeping people healthy.

Subscription Center
Join us on October 13, 2021 Join us on October 13, 2021